Mode
Text Size
Log in / Sign up

Machine learning models predict mortality in ICU patients with coronary artery disease

Machine learning models predict mortality in ICU patients with coronary artery disease
Photo by Natanael Melchor / Unsplash
Key Takeaway
Consider machine learning mortality prediction models for ICU CAD patients as promising but requiring prospective validation.

This retrospective cohort study developed and validated machine learning models to predict mortality in critically ill patients with coronary artery disease. Using data from 15,930 ICU patients (mean age 70.3 ± 12.1 years; 31.7% female) from the MIMIC-IV (training) and MIMIC-III (external validation) databases, researchers compared seven machine learning algorithms to predict 28-day and 365-day mortality risks.

The RandomForest algorithm demonstrated optimal performance. For 28-day mortality prediction, internal validation showed an AUC of 0.858 (95% CI: 0.843–0.872) with 88.2% accuracy, while external validation showed an AUC of 0.914 (95% CI: 0.904–0.923) with 91.4% accuracy. For 365-day mortality prediction, internal validation showed an AUC of 0.851 (95% CI: 0.840–0.863) with 79.6% accuracy, while external validation showed an AUC of 90.1 (95% CI: 0.893–0.909) with 85.3% accuracy.

Safety and tolerability data were not reported. The primary limitation is that clinical utility requires prospective validation, as noted by the authors. This study offers data-driven decision support for early identification of high-risk patients, but implementation should await further validation in prospective clinical settings.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedMar 2026
View Original Abstract ↓
Coronary artery disease (CAD) ranks among the most prevalent and clinically challenging cardiovascular disorders encountered in the intensive care unit (ICU). Patients with CAD admitted to the ICU typically exhibit elevated mortality rates, intricate pathophysiological alterations, and a high likelihood of adverse outcomes. This study aims to develop and validate a prognostic prediction model for ICU-admitted CAD patients using machine learning (ML) methodologies. The data were retrieved from two independent cohorts within the Medical Information Mart for Intensive Care (MIMIC) database: MIMIC-IV was utilized for model training, while MIMIC-III served as an external validation dataset. The primary endpoints of the prediction were the 28- and 365-day mortality risks in this patient population. Feature selection was performed using LASSO regression integrated with commonality analysis, and feature importance was quantified via the SHapley Additive exPlanations (SHAP) approach to identify critical risk factors. Subsequently, short-term and long-term mortality risk prediction models for patients with coronary artery disease were developed based on seven interpretable machine learning algorithms. A total of 15,930 patients with coronary artery disease were enrolled in this study (mean age, 70.3 ± 12.1 years; 5,055 females, accounting for 31.7%). To evaluate the mortality risk of patients across different time horizons, we developed predictive models incorporating 40 and 41 feature variables, respectively. Comparative analyses with six other machine learning algorithms revealed that the RandomForest algorithm exhibited the optimal performance in predicting both short-term and long-term mortality risks among patients with coronary artery disease [28-day mortality risk: Internal validation: AUC = 0.858, 95% CI: 0.843–0.872; Accuracy = 88.2%; External validation: AUC = 0.914, 95% CI: 0.904–0.923; Accuracy = 91.4%] [365-day mortality risk: Internal validation: AUC = 0.851, 95% CI: 0.840–0.863; Accuracy = 79.6%; External validation: AUC = 90.1, 95% CI: 0.893–0.909; Accuracy = 85.3%]. The random forest model developed in this study exhibited robust predictive performance and generalization capability in evaluating short-term and long-term mortality risks among critically ill patients with CAD. As a promising predictive tool, it offers data-driven decision support for clinicians to conduct early identification of high-risk patients and perform risk stratification, while its ultimate clinical utility remains to be further validated by prospective studies.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.